AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
Secukinumab in Kenya
1 product registered with PPB — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| FRAIZERON, secukinumab 150mg Powder For Injection | H2021/CTD8461/16389 | Novartis Overseas Investment AG | active | 20 Sept 2026 |
Secukinumab — PPB Registration Details
PPB (Kenya) has 1 registered product containing Secukinumab, of which 1 is currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track Secukinumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.